web hit counter

FDA Releases Month One of 55 Year Rollout For Pfizer COVID-19 Jab Data And It’s Already a Disaster

Remember when the FDA requested a federal judge allow them until 2076 to publicly release the data and information for the Pfizer COVID-19 injection?

Here’s a refresher from the FOIA request of the full disclosure for Pfizer’s data:

In the United States District Court for the Northern District of Texas, Public Health and Medical Professionals for Transparency issued a “FOIA” request for the full disclosure of data and information of the Pfizer COVID-19 jab.

The plaintiff requested the FDA provide the non-exempt portions of the information in four months.

But the FDA requested a slower rate of processing the 329,000+ pages of data produced by Pfizer.

The FDA proposed a processing rate of 500 pages per month.

For 329,000 pages, the FDA’s proposed rate would take a minimum of 658 months (55 years).

From the Second Joint Report:

After the December 1 production, FDA proposes to work through the list of documents that Plaintiff requested FDA prioritize for production in order of priority and process and release the non-exempt portions of those records to Plaintiff on a rolling basis. FDA proposes to process and produce the non-exempt portions of responsive records at a rate of 500 pages per month. This rate is consistent with processing schedules entered by courts across the country in FOIA cases.3 Plaintiff’s request (as set forth below) that FDA process and produce the non-exempt portions of more than 329,000 pages in four months would force FDA to process more than 80,000 pages per month. Undersigned counsel is not aware of any court ever granting such a request. The Court should decline to enter Plaintiff’s schedule for numerous reasons.

On Friday, the FDA produced the first 91+ pages of documents from the Pfizer COVID-19 jab.

Here’s what we found:


Pfizer explains, on page 6, that “Due to the large numbers of spontaneous adverse event reports received for the product, [Pfizer] has prioritised the processing of serious cases…” and that Pfizer “has also taken a [sic] multiple actions to help alleviate the large increase of adverse event reports” including “increasing the number of data entry and case processing colleagues” and “has onboarded approximately [REDACTED] additional fulltime employees (FTEs).” Query why it is proprietary to share how many people Pfizer had to hire to track all of the adverse events being reported shortly after launching its product.

As for the volume of reports, in the 2 ½ months following EUA, Pfizer received a total of 42,086 reports containing 158,893 “events.” Most of these reports were from the U.S. and disproportionately involved women (29,914 vs. 9,182 provided by men) and those between 31 and 50 years old (13,886 vs 21,325 for all other age groups combined, with another 6,876 whose ages were unknown). Also, 25,957 of the events were classified as “Nervous system disorders”

In the first 2.5 months of their COVID-19 jab rollout following EUA, Pfizer hired extra employees to track the high volume of adverse events.

Earlier reports and vaccine-injury testimonials hinted at the massive number of “nervous system disorders” following the Pfizer COVID-19 jab.


But the results from the disclosed Pfizer documents paint a more frightening tale.

And we still have 54 years and 11 months of data and information to dig through.


Leave a Comment

Your email address will not be published. Required fields are marked *